Literature DB >> 11061554

A role for activin A and betacellulin in human fetal pancreatic cell differentiation and growth.

C Demeterco1, G M Beattie, S A Dib, A D Lopez, A Hayek.   

Abstract

Activin A (Act.A), a member of the transforming growth factor beta family of secreted proteins, has been implicated in the regulation of growth and differentiation of various cell types. Betacellulin (BTC), a member of the epidermal growth factor family, converts exocrine AR42J cells to insulin-expressing cells when combined with Act.A. We have used primary cultures of human fetal pancreatic tissue to identify the effects of Act.A and/or BTC on islet development and growth. Exposure to Act.A resulted in a 1.5-fold increase in insulin content (P < 0.005) and a 2-fold increase in the number of cells immunopositive for insulin (P < 0.005). The formation of islet-like cell clusters, containing mainly epithelial cells, during a 5-day culture, was stimulated 1.4-fold by BTC (P < 0.05). BTC alone caused a 2.6-fold increase in DNA synthesis (P < 0.005). These data suggest that Act.A induces endocrine differentiation, whereas BTC has a mitogenic effect on human undifferentiated pancreatic epithelial cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11061554     DOI: 10.1210/jcem.85.10.6848

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  25 in total

Review 1.  Prospects for the prevention and reversal of type 1 diabetes mellitus.

Authors:  Nikolai Petrovsky; Diego Silva; Desmond A Schatz
Journal:  Drugs       Date:  2002       Impact factor: 9.546

2.  Nodal and lefty signaling regulates the growth of pancreatic cells.

Authors:  You-Qing Zhang; Lori Sterling; Aleksandr Stotland; Hong Hua; Marcie Kritzik; Nora Sarvetnick
Journal:  Dev Dyn       Date:  2008-05       Impact factor: 3.780

3.  Reciprocal modulation of adult beta cell maturity by activin A and follistatin.

Authors:  M Szabat; J D Johnson; J M Piret
Journal:  Diabetologia       Date:  2010-05-04       Impact factor: 10.122

4.  Association of a polymorphism in the betacellulin gene with type 1 diabetes mellitus in two populations.

Authors:  Kristi D Silver; Victoria L Magnuson; Magdalena Tolea; Jian Wang; William A Hagopian; Braxton D Mitchell
Journal:  J Mol Med (Berl)       Date:  2006-05-09       Impact factor: 4.599

5.  In vitro evaluation of different protocols for the induction of mesenchymal stem cells to insulin-producing cells.

Authors:  Fatemeh Seyedi; Alireza Farsinejad; Mojgan Moshrefi; Seyed Noureddin Nematollahi-Mahani
Journal:  In Vitro Cell Dev Biol Anim       Date:  2015-04-22       Impact factor: 2.416

6.  Association of childhood type 1 diabetes mellitus with a variant of PAX4: possible link to beta cell regenerative capacity.

Authors:  A Biason-Lauber; B Boehm; M Lang-Muritano; B R Gauthier; T Brun; C B Wollheim; E J Schoenle
Journal:  Diabetologia       Date:  2005-04-15       Impact factor: 10.122

7.  Proliferation of sorted human and rat beta cells.

Authors:  G Parnaud; D Bosco; T Berney; F Pattou; J Kerr-Conte; M Y Donath; C Bruun; T Mandrup-Poulsen; N Billestrup; P A Halban
Journal:  Diabetologia       Date:  2007-11-10       Impact factor: 10.122

8.  Increased activin bioavailability enhances hepatic insulin sensitivity while inducing hepatic steatosis in male mice.

Authors:  Nathan A Ungerleider; Lara M Bonomi; Melissa L Brown; Alan L Schneyer
Journal:  Endocrinology       Date:  2013-03-26       Impact factor: 4.736

9.  Defective valvulogenesis in HB-EGF and TACE-null mice is associated with aberrant BMP signaling.

Authors:  Leslie F Jackson; Ting Hu Qiu; Susan W Sunnarborg; Aileen Chang; Chunlian Zhang; Cam Patterson; David C Lee
Journal:  EMBO J       Date:  2003-06-02       Impact factor: 11.598

10.  Sodium butyrate and dexamethasone promote exocrine pancreatic gene expression in mouse embryonic stem cells.

Authors:  Meng Ren; Li Yan; Chang-zhen Shang; Jun Cao; Fang-ping Li; Jing-yi Li; Hua Cheng; Jun Min
Journal:  Acta Pharmacol Sin       Date:  2009-08-24       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.